Simple jQuery Dropdowns

Browsing by Author Francesca Aweeka

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
1-Jun-2018Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysisFrank Kloprogge; Lesley Workman; Steffen Borrmann; Mamadou Tékété; Gilbert Lefèvre; Kamal Hamed; Patrice Piola; Johan Ursing; Poul Erik Kofoed; Andreas Mårtensson; Billy Ngasala; Anders Björkman; Michael Ashton; Sofia Friberg Hietala; Francesca Aweeka; Sunil Parikh; Leah Mwai; Timothy M.E. Davis; Harin Karunajeewa; Sam Salman; Francesco Checchi; Carole Fogg; Paul N. Newton; Mayfong Mayxay; Philippe Deloron; Jean François Faucher; François Nosten; Elizabeth A. Ashley; Rose McGready; Michele van Vugt; Stephane Proux; Ric N. Price; Juntra Karbwang; Farkad Ezzet; Rajesh Bakshi; Kasia Stepniewska; Nicholas J. White; Philippe J. Guerin; Karen I. Barnes; Joel Tarning; Pharmetheus AB; Muhimbili University of Health and Allied Sciences; Bandim Health Project; Institut Pasteur du Cambodge; Kenya Medical Research Institute; Shoklo Malaria Research Unit; University of Western Australia; London School of Hygiene & Tropical Medicine; Universite Paris Descartes; Walter and Eliza Hall Institute of Medical Research; University of Oxford; Danderyd Hospital; Menzies School of Health Research; University of Portsmouth; University of California, San Francisco; Centre de Recherches Pour Le Développement International; UCL; Karolinska University Hospital; Universität Tübingen; Göteborgs Universitet; CHU de Limoges; Epicentre; Mahidol University; Karolinska Institutet; Nagasaki University; Novartis International AG; Yale University; Charles Darwin University; Uppsala Universitet; Amsterdam UMC - University of Amsterdam; University of Cape Town; Kolding Sygehus; WorldWide Antimalarial Resistance Network; University of Sciences; Novartis Pharmaceuticals; Wellcome Trust Research Unit; WorldWide Antimalarial Resistance Network; Myanmar Oxford Clinical Research Unit; World Wide Antimalarial Resistance Network (WWARN)-Asia Regional Centre; WorldWide Antimalarial Resistance Network; Afya Research Africa; University of Health Sciences
18-Sep-2015Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataElizabeth A. Ashley; Francesca Aweeka; Karen I. Barnes; Quique Bassat; Steffen Borrmann; Prabin Dahal; Timothy M.E. Davis; Mey Bouth Denis; Abdoulaye A. Djimde; Jean François Faucher; Blaise Genton; Philippe J. Guérin; Kamal Hamed; Eva Maria Hodel; Liusheng Huang; Vincent Jullien; Harin A. Karunajeewa; Jean René Kiechel; Poul Erik Kofoed; Gilbert Lefèvre; Niklas Lindegardh Lindegardh; Andreas Mårtensson; Mayfong Mayxay; Rose Mcgready; Clarissa Moreira; Paul N. Newton; Billy E. Ngasala; Francois Nosten; Christian Nsanzabana; Sunil Parikh; Patrice Piola; Ric N. Price; Pascal Ringwald; Lars Rombo; Birgit Schramm; Carol Hopkins Sibley; Kasia Stepniewska; Joel Tarning; Johan Ursing; Michele Van Vugt; Nicholas J. White; Lesley J. Workman; Philippe Deloron; Kevin Marsh; Shoklo Malaria Research Unit; Mahidol University; University of California, San Francisco; WorldWide Antimalarial Resistance Network (WWARN); University of Cape Town; Instituto de Salud Global de Barcelona; Centro de Investigação em Saúde de Manhiça (CISM); Wellcome Trust Research Laboratories Nairobi; Universitat Tubingen; Nuffield Department of Clinical Medicine; University of Western Australia; IRD Institut de Recherche pour le Developpement; Universite Paris Descartes; National Center for Parasitology; Organisation Mondiale de la Sante; University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology; Hopital Jean Minjoz; Swiss Tropical and Public Health Institute (Swiss TPH); Centre Hospitalier Universitaire Vaudois; Novartis Pharmaceuticals Corporation; Liverpool School of Tropical Medicine; Drugs for Neglected Diseases Initiative; Syddansk Universitet; Kolding Sygehus; Novartis International AG; Kenya Medical Research Institute; Karolinska Institutet; Wellcome Trust; Muhimbili University of Health and Allied Sciences; Yale Schools of Public Health and Medicine; Department of Clinical Pharmacology; Institut Pasteur de Madagascar; Menzies School of Health Research; Uppsala Universitet; Epicentre; University of Washington, Seattle; University of Amsterdam
1-Jan-2010Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, UgandaJulia Mwesigwa; Sunil Parikh; Bryan McGee; Polina German; Troy Drysdale; Joan N. Kalyango; Tamara D. Clark; Grant Dorsey; Niklas Lindegardh; Anna Annerberg; Philip J. Rosenthal; Moses R. Kamya; Francesca Aweeka; Makerere University Medical School; University of California, San Francisco; Mahidol University; Nuffield Department of Clinical Medicine
1-Oct-2018Population pharmacokinetics of the antimalarial amodiaquine: A pooled analysis to optimize dosingAli Mohamed Ali; Melissa A. Penny; Thomas A. Smith; Lesley Workman; Philip Sasi; George O. Adjei; Francesca Aweeka; Jean René Kiechel; Vincent Jullien; Marcus J. Rijken; Rose McGready; Julia Mwesigwa; Kim Kristensen; Kasia Stepniewska; Joel Tarning; Karen I. Barnes; Paolo Denti; Muhimbili University of Health and Allied Sciences; Ifakara Health Institute; Universite Paris Descartes; University of Oxford; University of California, San Francisco; Universitat Basel; Swiss Tropical and Public Health Institute (Swiss TPH); University of Ghana; Universiteit Antwerpen; Mahidol University; Nuffield Department of Clinical Medicine; Novo Nordisk A/S; University of Cape Town; Medical Research Council Unit; Drugs for Neglected Diseases Initiative